Impact on the carotid intima-medial thickness and safety of rosuvastatin in Chinese patients with carotid atherosclerosis: a meta-analysis / 中华心血管病杂志
Chinese Journal of Cardiology
; (12): 247-253, 2014.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-316482
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the efficacy and safety of rosuvastatin in Chinese patients with carotid atherosclerosis.</p><p><b>METHOD</b>A systematic search of Pubmed, EMBase, CENTRAL, CBMdisc, CNKI and WANFANG databases up to January 2013 was performed to identify studies comparing rosuvastatin with a placebo or other statins on carotid intima-medial thickness (IMT) with a minimum follow-up of 6 months in Chinese patients. Meta-analysis was performed by using RevMan 5.0 software after the strict evaluation of the methodological quality of the included studies independently by two reviewers.</p><p><b>RESULTS</b>Twenty-eight studies involving 1 392 individuals were included in this review. The pooled weighted mean difference (WMD) between rosuvastatin and placebo or control on IMT was 0.28 mm (95%CI 0.14-0.42, P < 0.01), with 0.31 mm (95%CI 0.14-0.49, P < 0.01) on 6-8 months and 0.16 mm (95%CI 0.05-0.27, P = 0.005) on 12 months, respectively. Analysis on studies in core journals showed the WMD between rosuvastatin and placebo or control on IMT was 0.18 mm (95%CI 0.09-0.27, P < 0.01). The WMD between rosuvastatin and other statins on IMT was 0.06 mm (95%CI 0.04-0.08, P < 0.01). The WMD between rosuvastatin and placebo or control on plaque score was 0.89 (95%CI 0.78-0.99, P < 0.01). The WMD between rosuvastatin and placebo or control on plaque area was 1.46 (95%CI 0.67-2.25, P < 0.01).Reports of adverse effect were elevated liver enzyme (2.30%, 19/825), elevated muscle enzyme (0.73%, 6/825), muscle aches (0.61%, 5/825).</p><p><b>CONCLUSIONS</b>Rosuvastatin therapy is effective and safe to decrease IMT in Chinese patients with carotid atherosclerosis.</p>
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pirimidinas
/
Sulfonamidas
/
Diagnóstico por Imagem
/
Doenças das Artérias Carótidas
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Espessura Intima-Media Carotídea
/
Rosuvastatina Cálcica
/
Fluorbenzenos
Tipo de estudo:
Ensaio clínico controlado
/
Estudo diagnóstico
/
Estudo prognóstico
/
Revisão sistemática
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
Chinese Journal of Cardiology
Ano de publicação:
2014
Tipo de documento:
Artigo